Telecare Market Size, Share & Trends Analysis Report By Type (Activity Monitoring, Remote Medication Management), By Region (orth America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2024 - 2030
Telecare Market Growth & Trends
The global telecare market size is anticipated to reach USD 6.34 billion by 2030, registering a CAGR of 5.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. Telecare provides services mainly to vulnerable and elderly individuals for immediate contact with someone for help in case of any emergency. In addition, the increasing development of new technology, from telephones to online virtual visits, has shaped the face of modern healthcare services. Thus, technological advancements have played a crucial role in driving the market growth. Innovations, such as wearable devices, remote monitoring systems, and telemedicine platforms, have revolutionized healthcare delivery by enabling real-time health monitoring, virtual consultations, and remote patient management. For instance, in June 2023, Telecare introduced RxPad, Australia's standalone platform for electronic prescriptions.
Designed by clinicians for clinicians, this innovative solution aims to replace traditional paper prescriptions. RxPad is poised to revolutionize healthcare delivery, improving patient experiences and empowering doctors, making consultations more efficient and enjoyable for everyone involved. This innovative device offers the most advanced features in the market. Moreover, the growing aging population is a significant factor propelling market expansion. With the growing aging population, the demand for healthcare services increases, particularly for chronic disease management and elderly care. Telecare offers a viable solution to meet these demands by providing continuous monitoring and support for older adults. It enables elderly patients to live independently while ensuring they receive timely medical attention.
This demographic shift is creating a substantial market for telecare solutions that cater to the specific needs of older individuals, promoting safety, health, and well-being in an aging society. Furthermore, the increasing prevalence of chronic diseases and rising demand for personalized healthcare solutions have propelled the adoption of telecare technologies. Chronic conditions, such as diabetes, hypertension, and heart disease, require continuous monitoring and management, which can be effectively facilitated through remote monitoring solutions. Telecare enables proactive disease management, early detection of complications, and timely interventions, leading to improved patient outcomes and reduced healthcare costs in the long run. The market is poised for continued growth as healthcare stakeholders recognize the transformative potential of remote monitoring and care management solutions in delivering accessible, cost-effective, and patient-centered healthcare services.
Telecare Market Report Highlights
- The activity monitoring segment held the largest share of 59.42% in 2023. This expansion can be attributed to several factors, including the aging population, increased prevalence of chronic diseases, and advancements in technology
- North America dominated the global market and accounted for a revenue share of 48.94% in 2023. This is attributed to several factors, such as the high penetration of smartphones and the internet, growing awareness among individuals to maintain physical health, and the use of remote healthcare services
- The market is highly competitive with key players, such as Teladoc Health, Inc. and Abbott Laboratories, holding significant positions. The major companies are undertaking various strategies, such as new product development, collaborations, acquisitions, mergers, and regional expansions, to serve the unmet needs of their customers
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Regional Scope
- 1.2.3. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
- Chapter 3. Telecare Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Telecare Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- 3.4. Technology Timeline Analysis
- 3.5. User Case Studies/ End-Use Case Studies
- Chapter 4. Telecare Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Telecare Market: Type Movement Analysis
- 4.3. Telecare Market by Type Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Activity Monitoring
- 4.5.1. Activity Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Remote Medication Management
- 4.6.1. Remote Medication Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 5. Telecare Market: Regional Estimates & Trend Analysis
- 5.1. Regional Dashboard
- 5.2. Regional Telecare Market movement analysis
- 5.3. Telecare Market: Regional Estimates & Trend Analysis by Type
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. North America
- 5.5.1. North America Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.2. U.S.
- 5.5.2.1. Key Country Dynamics
- 5.5.2.2. Competitive Scenario
- 5.5.2.3. Regulatory Framework
- 5.5.2.4. U.S. Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.3. Canada
- 5.5.3.1. Key Country Dynamics
- 5.5.3.2. Competitive Scenario
- 5.5.3.3. Regulatory Framework
- 5.5.3.4. Canada Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.4. Mexico
- 5.5.4.1. Key Country Dynamics
- 5.5.4.2. Competitive Scenario
- 5.5.4.3. Regulatory Framework
- 5.5.4.4. Reimbursement scenario
- 5.5.4.5. Mexico Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Europe
- 5.6.6. Europe Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.7. UK
- 5.6.7.1. Key Country Dynamics
- 5.6.7.2. Competitive Scenario
- 5.6.7.3. Regulatory Framework
- 5.6.7.4. UK Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.8. Germany
- 5.6.8.1. Key Country Dynamics
- 5.6.8.2. Competitive Scenario
- 5.6.8.3. Regulatory Framework
- 5.6.8.4. Reimbursement scenario
- 5.6.8.5. Germany Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.9. France
- 5.6.9.1. Key Country Dynamics
- 5.6.9.2. Competitive Scenario
- 5.6.9.3. Regulatory Framework
- 5.6.9.4. France Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.10. Italy
- 5.6.10.1. Key Country Dynamics
- 5.6.10.2. Competitive Scenario
- 5.6.10.3. Regulatory Framework
- 5.6.10.4. Italy Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.11. Spain
- 5.6.11.1. Key Country Dynamics
- 5.6.11.2. Competitive Scenario
- 5.6.11.3. Regulatory Framework
- 5.6.11.4. Spain Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.12. Denmark
- 5.6.12.1. Key Country Dynamics
- 5.6.12.2. Competitive Scenario
- 5.6.12.3. Regulatory Framework
- 5.6.12.4. Denmark Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.13. Norway
- 5.6.13.1. Key Country Dynamics
- 5.6.13.2. Competitive Scenario
- 5.6.13.3. Regulatory Framework
- 5.6.13.4. Norway Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.14. Sweden
- 5.6.14.1. Key Country Dynamics
- 5.6.14.2. Competitive Scenario
- 5.6.14.3. Regulatory Framework
- 5.6.14.4. Sweden Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.14.5.
- 5.7. Asia Pacific
- 5.7.1. Asia Pacific Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.2. Japan
- 5.7.2.1. Key Country Dynamics
- 5.7.2.2. Competitive Scenario
- 5.7.2.3. Regulatory Framework
- 5.7.2.4. Japan Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.3. China
- 5.7.3.1. Key Country Dynamics
- 5.7.3.2. Competitive Scenario
- 5.7.3.3. Regulatory Framework
- 5.7.3.4. China Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.4. India
- 5.7.4.1. Key Country Dynamics
- 5.7.4.2. Competitive Scenario
- 5.7.4.3. Regulatory Framework
- 5.7.4.4. India Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.5. South Korea
- 5.7.5.1. Key Country Dynamics
- 5.7.5.2. Competitive Scenario
- 5.7.5.3. Regulatory Framework
- 5.7.5.4. South Korea Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.6. Australia
- 5.7.6.1. Key Country Dynamics
- 5.7.6.2. Competitive Scenario
- 5.7.6.3. Regulatory Framework
- 5.7.6.4. Australia Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.7. Thailand
- 5.7.7.1. Key Country Dynamics
- 5.7.7.2. Competitive Scenario
- 5.7.7.3. Regulatory Framework
- 5.7.7.4. Thailand Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Latin America
- 5.8.1. Latin America Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8.2. Brazil
- 5.8.2.1. Key Country Dynamics
- 5.8.2.2. Competitive Scenario
- 5.8.2.3. Regulatory Framework
- 5.8.2.4. Brazil Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8.3. Argentina
- 5.8.3.1. Key Country Dynamics
- 5.8.3.2. Competitive Scenario
- 5.8.3.3. Regulatory Framework
- 5.8.3.4. Argentina Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9. Middle East & Africa
- 5.9.1. Middle East & Africa Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.2. South Africa
- 5.9.2.1. Key Country Dynamics
- 5.9.2.2. Competitive Scenario
- 5.9.2.3. Regulatory Framework
- 5.9.2.4. South Africa Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.3. Saudi Arabia
- 5.9.3.1. Key Country Dynamics
- 5.9.3.2. Competitive Scenario
- 5.9.3.3. Regulatory Framework
- 5.9.3.4. Saudi Arabia Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.4. UAE
- 5.9.4.1. Key Country Dynamics
- 5.9.4.2. Competitive Scenario
- 5.9.4.3. Regulatory Framework
- 5.9.4.4. UAE Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.5. Kuwait
- 5.9.5.1. Key Country Dynamics
- 5.9.5.2. Competitive Scenario
- 5.9.5.3. Regulatory Framework
- 5.9.5.4. Kuwait Telecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Competitive Landscape
- 6.1. Market Participant Categorization
- 6.2. Key Company Profiles
- 6.2.1. Teladoc Health, Inc.
- 6.2.1.1. Company overview
- 6.2.1.2. Financial performance
- 6.2.1.3. Product benchmarking
- 6.2.1.4. Strategic initiatives
- 6.2.2. Abbott Laboratories
- 6.2.2.1. Company overview
- 6.2.2.2. Financial performance
- 6.2.2.3. Product benchmarking
- 6.2.2.4. Strategic initiatives
- 6.2.3. Johnson and Johnson
- 6.2.3.1. Company overview
- 6.2.3.2. Financial performance
- 6.2.3.3. Product benchmarking
- 6.2.3.4. Strategic initiatives
- 6.2.4. AstraZeneca PLC
- 6.2.4.1. Company overview
- 6.2.4.2. Financial performance
- 6.2.4.3. Product benchmarking
- 6.2.4.4. Strategic initiatives
- 6.2.5. F. Hoffmann-La Roche Ltd.
- 6.2.5.1. Company overview
- 6.2.5.2. Financial performance
- 6.2.5.3. Product benchmarking
- 6.2.5.4. Strategic initiatives
- 6.2.6. Novartis AG
- 6.2.6.1. Company overview
- 6.2.6.2. Financial performance
- 6.2.6.3. Product benchmarking
- 6.2.6.4. Strategic initiatives
- 6.2.7. NeoRehab
- 6.2.7.1. Company overview
- 6.2.7.2. Financial performance
- 6.2.7.3. Product benchmarking
- 6.2.7.4. Strategic initiatives
- 6.2.8. Bristol-Myers Squibb Company
- 6.2.8.1. Company overview
- 6.2.8.2. Financial performance
- 6.2.8.3. Product benchmarking
- 6.2.8.4. Strategic initiatives
- 6.2.9. GlaxoSmithKline plc
- 6.2.9.1. Company overview
- 6.2.9.2. Financial performance
- 6.2.9.3. Product benchmarking
- 6.2.9.4. Strategic initiatives
- 6.2.10. Merck and Co., Inc.
- 6.2.10.1. Company overview
- 6.2.10.2. Financial performance
- 6.2.10.3. Product benchmarking
- 6.2.10.4. Strategic initiatives
- 6.2.11. Pfizer, Inc.
- 6.2.11.1. Company overview
- 6.2.11.2. Financial performance
- 6.2.11.3. Product benchmarking
- 6.2.11.4. Strategic initiatives
- 6.2.12. Sanofi
- 6.2.12.1. Company overview
- 6.2.12.2. Financial performance
- 6.2.12.3. Product benchmarking
- 6.2.12.4. Strategic initiatives
- 6.2.13. Samsung Electronics Co. Ltd
- 6.2.13.1. Company overview
- 6.2.13.2. Financial performance
- 6.2.13.3. Product benchmarking
- 6.2.13.4. Strategic initiatives
- 6.2.14. Qualcomm Technologies, Inc.
- 6.2.14.1. Company overview
- 6.2.14.2. Financial performance
- 6.2.14.3. Product benchmarking
- 6.2.14.4. Strategic initiatives
- 6.2.15. Orange
- 6.2.15.1. Company overview
- 6.2.15.2. Financial performance
- 6.2.15.3. Product benchmarking
- 6.2.15.4. Strategic initiatives
- 6.2.16. Google (Alphabet), Inc
- 6.2.16.1. Company overview
- 6.2.16.2. Financial performance
- 6.2.16.3. Product benchmarking
- 6.2.16.4. Strategic initiatives
- 6.2.17. Allscripts
- 6.2.17.1. Company overview
- 6.2.17.2. Financial performance
- 6.2.17.3. Product benchmarking
- 6.2.17.4. Strategic initiatives
- 6.2.18. Apple, Inc.
- 6.2.18.1. Company overview
- 6.2.18.2. Financial performance
- 6.2.18.3. Product benchmarking
- 6.2.18.4. Strategic initiatives
- 6.2.19. AT&T
- 6.2.19.1. Company overview
- 6.2.19.2. Financial performance
- 6.2.19.3. Product benchmarking
- 6.2.19.4. Strategic initiatives
- 6.2.20. Airstrip Technologies, Inc
- 6.2.20.1. Company overview
- 6.2.20.2. Financial performance
- 6.2.20.3. Product benchmarking
- 6.2.20.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook